1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
01/08/2024 | CBT | Buy Now | Cabot | $88.10 | -1.25% | UBS | Joshua Spector | $90 → $87 | Downgrade | Buy → Neutral | Get Alert |
12/14/2023 | CBT | Buy Now | Cabot | $88.10 | 2.16% | UBS | Joshua Spector | $83 → $90 | Maintains | Buy | Get Alert |
11/07/2023 | CBT | Buy Now | Cabot | $88.10 | -5.79% | UBS | Joshua Spector | $86 → $83 | Maintains | Buy | Get Alert |
08/11/2023 | CBT | Buy Now | Cabot | $88.10 | -20.54% | JP Morgan | Jeffrey Zekauskas | $68 → $70 | Maintains | Neutral | Get Alert |
08/08/2023 | CBT | Buy Now | Cabot | $88.10 | -6.92% | Credit Suisse | John Roberts | $85 → $82 | Maintains | Outperform | Get Alert |
06/20/2023 | CBT | Buy Now | Cabot | $88.10 | 16.91% | Loop Capital | Christopher Kapsch | $111 → $103 | Maintains | Buy | Get Alert |
06/06/2023 | CBT | Buy Now | Cabot | $88.10 | -9.19% | JP Morgan | Jeffrey Zekauskas | $87 → $80 | Downgrade | Overweight → Neutral | Get Alert |
05/18/2023 | CBT | Buy Now | Cabot | $88.10 | -9.19% | Deutsche Bank | David Begleiter | $90 → $80 | Maintains | Buy | Get Alert |
05/09/2023 | CBT | Buy Now | Cabot | $88.10 | 3.29% | Credit Suisse | John Roberts | $94 → $91 | Maintains | Outperform | Get Alert |
03/13/2023 | CBT | Buy Now | Cabot | $88.10 | 6.7% | Credit Suisse | John Roberts | → $94 | Initiates | → Outperform | Get Alert |
02/13/2023 | CBT | Buy Now | Cabot | $88.10 | 28.26% | Loop Capital | Christopher Kapsch | $98 → $113 | Maintains | Buy | Get Alert |
02/13/2023 | CBT | Buy Now | Cabot | $88.10 | -1.25% | JP Morgan | Jeffrey Zekauskas | $80 → $87 | Maintains | Overweight | Get Alert |
11/16/2022 | CBT | Buy Now | Cabot | $88.10 | 2.16% | Deutsche Bank | David Begleiter | $80 → $90 | Upgrade | Hold → Buy | Get Alert |
05/17/2022 | CBT | Buy Now | Cabot | $88.10 | -16% | Deutsche Bank | David Begleiter | $65 → $74 | Maintains | Hold | Get Alert |
01/04/2022 | CBT | Buy Now | Cabot | $88.10 | -20.54% | UBS | Joshua Spector | $75 → $70 | Maintains | Buy | Get Alert |
12/03/2021 | CBT | Buy Now | Cabot | $88.10 | -18.27% | Barclays | Michael Leithead | — | Maintains | Overweight | Get Alert |
07/23/2021 | CBT | Buy Now | Cabot | $88.10 | -29.63% | JP Morgan | Jeffrey Zekauskas | — | Upgrade | Neutral → Overweight | Get Alert |
07/01/2021 | CBT | Buy Now | Cabot | $88.10 | -11.46% | Loop Capital | Chris Kapsch | — | Upgrade | Hold → Buy | Get Alert |
05/05/2021 | CBT | Buy Now | Cabot | $88.10 | -17.14% | Northcoast Research | Kevin Hocevar | — | Upgrade | Neutral → Buy | Get Alert |
The latest price target for Cabot (NYSE: CBT) was reported by UBS on January 8, 2024. The analyst firm set a price target for $87.00 expecting CBT to fall to within 12 months (a possible -1.25% downside). 9 analyst firms have reported ratings in the last year.
The latest analyst rating for Cabot (NYSE: CBT) was provided by UBS, and Cabot downgraded their neutral rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cabot, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cabot was filed on January 8, 2024 so you should expect the next rating to be made available sometime around January 8, 2025.
While ratings are subjective and will change, the latest Cabot (CBT) rating was a downgraded with a price target of $90.00 to $87.00. The current price Cabot (CBT) is trading at is $88.10, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.